FAU.de
Deutsch
Login
Home
Publications
Research Grants
Inventions & Patents
Awards
Additional Research Activities
Faculties & Institutions
Research Areas
Katharina Marie Habenicht
List of publications:
BibTeX-Download
Professur für Genetik
Department of Medicine 5 – Haematology and Oncology
Publications
(8)
Types of publications
Toggle all
Journal article
Journal article
Book chapter / Article in edited volumes
Book chapter / Article in edited volumes
Authored book
Authored book
Translation
Translation
Thesis
Thesis
Edited Volume
Edited Volume
Conference contribution
Conference contribution
Other publication type
Other publication type
Unpublished / Preprint
Unpublished / Preprint
Publication year
From
To
Abstract
Journal
Filters (inactive)
Author Correction: Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus. (2023)
Mackensen A, Müller F, Mougiakakos D, Böltz S, Wilhelm A, Aigner M, Völkl S, et al.
Journal article, Erratum
Class switch towards non-inflammatory, spike-specific IgG4 antibodies after repeated SARS-CoV-2 mRNA vaccination (2022)
Irrgang P, Gerling J, Kocher K, Lapuente D, Steininger P, Habenicht KM, Wytopil M, et al.
Journal article
Expansion of Plasmablasts at Day 90 after Allogeneic Stem Cell Transplantation Predict Chronic Gvhd (2022)
Habenicht KM, Bootz A, Schäfer S, Vasova I, Fante M, Schneider A, Rehli M, et al.
Conference contribution
CD19-Targeted CAR-T Cells in Refractory Systemic Lupus Erythematosus: Safety, Efficacy, and Mechanistic Insights from the First Five Patients (2022)
Müller F, Völkl S, Mougiakakos D, Böltz S, Aigner M, Gary R, Kretschmann S, et al.
Conference contribution
Dysregulation of the B lymphocyte compartment in patients with chronic graft-versus-host disease (2022)
Habenicht KM, Bootz A, Schneider A, Schäfer S, Hoffmann P, Winkler J, Wolff D, Winkler T
Conference contribution
Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus (2022)
Mackensen A, Müller F, Mougiakakos D, Böltz S, Wilhelm A, Aigner M, Völkl S, et al.
Journal article
SARS-CoV-2 in severe COVID-19 induces a TGF-β-dominated chronic immune response that does not target itself (2021)
Ferreira-Gomes M, Kruglov A, Durek P, Heinrich F, Tizian C, Heinz GA, Pascual-Reguant A, et al.
Journal article
A pair of non‐competing neutralizing human monoclonal antibodies protecting from disease in a SARS‐CoV‐2 infection model (2021)
Peter AS, Roth E, Schulz S, Fraedrich K, Steinmetz T, Damm D, Hauke M, et al.
Journal article, Original article